CJC-1295 + Ipamorelin

This blend combines CJC-1295 (a growth hormone-releasing hormone analog) with Ipamorelin (a selective growth hormone secretagogue). Together they work through complementary pathways to stimulate growth hormone release. CJC-1295 extends the half-life of endogenous GHRH signaling, while Ipamorelin provides a targeted GH pulse without significantly affecting cortisol or prolactin. This combination is among the most researched GH-related peptide protocols.